Press releases.
Press releases 2025
Press releases 2025
Immutep Quarterly Activities Report Q2 FY25
January 31st 2025
Patient Enrolment Completed for EFTISARC-NEO Phase II Trial
January 22nd 2025
Patient Enrolment Completed for INSIGHT-003
January 6th 2025